Other potential limitations include assessing for pLoF in oncogenic candidates such as RET, ROS1, FGFR4, and MYC, while FAT1 and LEF1 reported to oscillate between oncogenic and tumour suppressive behaviour. The gene discussed is LEF1; the disease is neoplasm.